Momentum Biotechnologies, formerly known as Pure Honey Technologies, is a leading Contract Research Organization (CRO) specializing in mass spectrometry-based native detection technologies for lead discovery and quantification of challenging targets in the biopharmaceutical industry worldwide.
The company is dedicated to providing innovative solutions to biopharmaceutical clients, offering expertise in cutting-edge analytical techniques to support drug development and research initiatives.
Generated from the website